This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Gerardo Garcia Lerma: Innovator in Antiviral Drug Resistance Detection
Introduction
Gerardo Garcia Lerma is a notable inventor based in Atlanta, GA (US). He has made significant contributions to the field of antiviral research, particularly in the detection of drug resistance in retroviruses. His innovative work has implications for improving treatment strategies for viral infections.
Latest Patents
Gerardo Garcia Lerma holds a patent for a "Method and kit for detecting resistance to antiviral drugs." This patent describes an assay and kit designed to detect phenotypic resistance of a retrovirus to a reverse transcriptase inhibitor drug in a biological sample. The assay is based on the direct analysis of the susceptibility of retroviral reverse transcriptase to inhibition by the drug. The enzymatic activity of the reverse transcriptase is determined by measuring the DNA product produced when an RNA template and a first complementary DNA primer from a suitable region of the encephalomyocarditis virus genome are incubated with a biological sample containing reverse transcriptase in the presence of the drug to which resistance is being determined. This innovative approach enhances the understanding of drug resistance mechanisms.
Career Highlights
Gerardo Garcia Lerma has dedicated his career to advancing the field of antiviral research. He works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has been instrumental in developing methods that can lead to more effective treatments for patients suffering from viral infections.
Collaborations
Throughout his career, Gerardo has collaborated with esteemed colleagues, including William M. Switzer and Shinji Yamamoto. These collaborations have fostered a productive environment for research and innovation in the field of antiviral drug resistance.
Conclusion
Gerardo Garcia Lerma's contributions to the detection of antiviral drug resistance are invaluable. His innovative patent and dedication to research continue to impact the field positively. His work exemplifies the importance of innovation in addressing public health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile